| Literature DB >> 24019852 |
Lina Wu1, Micah Luderer, Xiaoxia Yang, Corban Swain, Huiying Zhang, Kate Nelson, Allen J Stacy, Baozhong Shen, Gregory M Lanza, Dipanjan Pan.
Abstract
A superior and commercially exploitable 'green synthesis' of optically active carbon nanoparticle (OCN) is revealed in this work. The naked carbon particles (<20 nm) were derived from commercial food grade honey. The fluorescence properties of these particles were significantly enhanced by utilizing hyberbranched polymer for surface passivation. A dramatic increase in near infrared emission was achieved compared to a linear polymer (PEG) coated carbon nanoparticles. Interestingly, as passivating agent becomes more extensively branched (pseudo generation 2 to 4), the average radiant efficiency amplifies considerably as a direct result of the increasing surface area available for light passivation. The particles showed negligible loss of cell viability in presence of endothelial cells in vitro. Preliminary in vivo experiment showed high contrast enhancement in auxiliary lymphnode in a mouse model. The exceptionally rapid lymphatic transport of these particles suggests that such an approach may offer greater convenience and reduced procedural expense, as well as improved surgical advantage as the patient is positioned on the table for easier resection.Entities:
Keywords: Carbon nanoparticle; contrast agent; hyperbranched polymer; near infrared imaging; surface passivation.
Mesh:
Substances:
Year: 2013 PMID: 24019852 PMCID: PMC3767114 DOI: 10.7150/thno.6535
Source DB: PubMed Journal: Theranostics ISSN: 1838-7640 Impact factor: 11.556
Fig 1Synthesis of OCN: (a) commercial grade honey (neat), passivating agent: hyper-branched polymer or polyethyleneglycol (MW = 400 Da), microwave, isolation of particles; (b) chemical structures of the macromolecules used for surface passivation; (c) representative solubility pattern of polyethyleneglycol coated OCN; (d) table summarizing the synthetic conditions and OCN physical properties.
Fig 2Physico-chemical characterizations of OCNs. (a) hydrated state number-averaged hydrodynamic diameter (dynamic light scattering) of as-synthesized G4-HBP-OCN dispersed (0.2 μM) in deionized water; (b) anhydrous state TEM images of G4-HBP-OCN drop deposited over nickel grid (scale bar 200 nm and 100 nm respectively); (c) particle size distribution from TEM; (d) SEM image of the as-synthesized OCN sample (gold/palladium coated, scale bar 2 μm); (e) particle height distribution (Hav) from AFM; (f) variation of zeta potential with pH; (g) FT-IR spectroscopy signals of as-synthesized OCN; (h) Raman spectrum of G4-HBP-OCN (baseline corrected).
Fig 3(a) UV-vis absorption spectra of OCNs (G2, G3 and G4 coated); (b) the corresponding normalized emission spectra at different excitation wavelengths; (c) PL spectra comparison for freshly prepared G4 HBP-OCN and after continuous irradiation for 16h (λex=350); (d) parameters for quantum yield calculated for OCNs.
Fig 4Fluorescence imaging of OCN in suspension with Xenogen-IVIS system. Fluorescence signals generated from a cell culture well plate filled with serially diluted OCN at 1:2, 1:4, 1:8, 1:16, 1:32 and the original volume concentration for column one is 200 mg/mL (1: G2-HBP-OCN; 2: G3-HBP-OCN; 3: G4-HBP-OCN; 4: Linear-PEG-OCN), a) excited at 745 nm and emission at 820 nm; b) excited at 430 nm and emission at 660 nm; c) average radiant efficiency obtained by ROI linear regression analysis against OCN concentration showing a dramatic increase in fluorescence efficiency at NIR range for hyperbranched polymer capped OCNs; d) average radiant efficiency against OCN concentration at the visible range showing moderate to no considerable enhancement; e) comparative summary of excitation and emission wavelengths for G4-HBP-OCN and linear PEG-OCN.
Fig 5(a) cell viability of OCN in 2F2B endothelial cells; (b) clinical pathology and serum chemistry results for OCN and untreated mice; non-invasive in vivo fluorescence imaging of SLN in mouse: fast accumulation of OCN in popliteal lymph node post injection (c) 1 min and (d) 30 min; (e) excised lymphnode showing the accumulation of dark deposit of carbon particles (yellow arrow), inset: a control excised lymphnode from untreated mice showing no visible accumulation of OCN; qualitative tissue distribution of OCN: 2h (f-g) and 24h (h-i) tissue accumulation of intradermally and intravenously injected OCN.